India has approved QDENGA, its first dengue vaccine. A pulmonary specialist explains who should get vaccinated, who should ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

This common viral infection currently has no cure, but healthcare experts are hopeful forthcoming clinical trials will have ...

By Uditha Jayasinghe COLOMBO, July 21 (Reuters) - Sri Lanka's public health services and hospitals are battling the worst ...

Forbes contributors publish independent expert analyses and insights. I’m an infectious diseases physician, scientist, leader, and entrepreneur. Dengue is a miserable illness caused by infection with ...

Takeda's QDENGA has been approved for people aged 4–60, offering a new prevention tool as dengue cases and the wider disease ...

The vaccine has been cleared for use in individuals aged 4 to 60 years and can be administered irrespective of whether the ...

Malaysia, Thailand and Brazil will begin Phase III trials in 2027 for SII-DNDi's dengue antibody treatment. If successful, it ...

April 7 is World Health Day 2014 and the theme this year is 'Vector-borne diseases small bite, big threat'. One of the most common vector-borne diseases in India is dengue or dengue fever which ...

Noida has identified multiple dengue hotspots as cases rise, deploying health teams, fogging drives, and awareness campaigns ...

A new study suggests adults with type 2 diabetes may be more likely to develop severe dengue, highlighting the importance of ...

India faces health risks from multiple strains of dengue that break out in clusters. These outbreaks are becoming ...